Adoptive transfer and specific active immunization of patients with malignant melanoma.
D000935:Antifungal Agents / Q000276:immunology; D000951:Antigens, Neoplasm; D001500:BCG Vaccine / Q000627:therapeutic use; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007109:Immunity; D007111:Immunity, Cellular; D007167:Immunotherapy; D008214:Lymphocytes / Q000276:immunology; D008545:Melanoma / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D009439:Neuraminidase / Q000494:pharmacology; D009657:North Carolina; D012882:Skin Tests; D014374:Tuberculin Test
D000935:Antifungal Agents; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D009439:Neuraminidase